Live Mahavir Advanced Remedies Share Price Chart

Chart is not available for Mahavir Advanced Remedies. Please visit after some time.

Mahavir Advanced Remedies Performance

Days Range

Low: ₹150.65
High: ₹150.65
Previous Close ₹153.70
Open ₹150.65
Volume 4,004
Day’s Range ₹150.65 - ₹150.65
52W Range ₹0.00 - ₹150.65
Market Cap ₹171.14 Cr

Mahavir Advanced Remedies Fundamentals

ROCE (TTM)
P/E Ratio (TTM)
P/B Ratio
Industry P/E
Debt to Equity
ROE
EPS (TTM)
Dividend Yield
Book Value
Face Value

Mahavir Advanced Remedies Financials

Financials data is not available for Mahavir Advanced Remedies. Please visit after some time.

About Mahavir Advanced Remedies

Incorporated in 1992, Indo American Advance Pharmaceuitcals (IAAPL) is promoted by V Koteswara Rao, B V S Kkoteswara Rao and T Ramakrishna. The company is now setting up a project for manufacturing ... Read More

Parent Organisation Indian Private
Founded 1992
Managing Director BVS Kotewara Rao
BSE Symbol MAHAREM

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,749.29

341.1

17.00 (-4.75%)

336.85 - 361.65
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹50.15

45.6

0.35 (0.77%)

45.6 - 47
Procter & Gamble Health Ltd ₹8,443.26

5089.25

8.85 (0.17%)

5050 - 5110.5
Veerhealth Care Ltd ₹49.44

26

0.00 (0.00)

26 - 26

What's Trending

Mahavir Advanced Remedies FAQs

What is the Share price of Mahavir Advanced Remedies (MAHAREM)?

Mahavir Advanced Remedies (MAHAREM) share price as of January 6, 2015, on BSE is Rs 150.65 (BSE).

Can I buy Mahavir Advanced Remedies (MAHAREM) shares?

Yes, You can buy Mahavir Advanced Remedies (MAHAREM) shares by opening a Demat account with Angel One.

How do I buy Mahavir Advanced Remedies (MAHAREM) from Angel One?

Mahavir Advanced Remedies (MAHAREM) share can be brought through the following modes:
  1. Direct investment: You can buy Mahavir Advanced Remedies (MAHAREM) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Mahavir Advanced Remedies (MAHAREM) shares.